Note: This is a Forecasted Opportunity.
The purpose of this NOFO is to improve awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding.The NOFO strategies are to:(1) TRACK – Conduct public health surveillance for AGS. This strategy could involve patient populations or geographic locations with limited access to specialized healthcare provider care. Health equity impacts should be considered.(2) EDUCATE – Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, etc.). Communications targeted at healthcare providers, healthcare provider educational resources, and training would also fall under this strategy.(3) SHARE – Disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response.
Estimated Post Date:
Nov 15, 2024
Estimated Application Due Date:
Jan 22, 2025
Sponsor Institute/Organizations: Centers for Disease Control and Prevention
Address: Centers for Disease Control and Prevention Office of Science Quality 1600 Clifton Road, NE Mail Stop D-72 Atlanta, Georgia 30333
Jan 22, 2025
Varies
Affiliation: Centers for Disease Control and Prevention
Address: Centers for Disease Control and Prevention Office of Science Quality 1600 Clifton Road, NE Mail Stop D-72 Atlanta, Georgia 30333
Website URL: https://www.zintellect.com/Opportunity/Details/CDC-NCCDPHP-DHDSP-2024-0148
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.